Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Operating Expenses (2023 - 2026)

Rallybio's Operating Expenses history spans 3 years, with the latest figure at $6.6 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 43.04% to $6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.9 million, a 44.51% decrease, with the full-year FY2025 number at $33.9 million, down 44.51% from a year prior.
  • Operating Expenses hit $6.6 million in Q4 2025 for Rallybio, down from $7.1 million in the prior quarter.
  • Over the last five years, Operating Expenses for RLYB hit a ceiling of $21.1 million in Q4 2023 and a floor of $6.6 million in Q4 2025.
  • Historically, Operating Expenses has averaged $14.5 million across 3 years, with a median of $14.8 million in 2024.
  • Biggest five-year swings in Operating Expenses: rose 7.69% in 2024 and later plummeted 50.06% in 2025.
  • Tracing RLYB's Operating Expenses over 3 years: stood at $21.1 million in 2023, then crashed by 44.84% to $11.6 million in 2024, then crashed by 43.04% to $6.6 million in 2025.
  • Business Quant data shows Operating Expenses for RLYB at $6.6 million in Q4 2025, $7.1 million in Q3 2025, and $10.3 million in Q2 2025.